A Phase 1, First-in-Human Study of DS-9606a in Patients with Tumor Types Known to Express Claudin-6 (CLDN6)

Disease:

Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Germ Cell Tumor

Study phase:

Phase I

Physician name:

Sarina Piha-Paul

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-844-502-9154